Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
06/2004
06/30/2004EP1432682A1 Process for the preparation of repaglinide
06/30/2004EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
06/29/2004US6756400 Diaromatic compound containing 2-amine groups, useful for treating neuropathic pain
06/29/2004US6756380 5-phenyl-pyrimidine derivatives
06/29/2004US6756378 VLA-4 inhibitor compounds
06/29/2004US6756375 Estrogen receptor modulation; hormone replacement therapy
06/29/2004US6756374 Diaminothiazoles having antiproliferative activity
06/29/2004US6756365 Reducing tetracycline resistance in living cells
06/29/2004US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/24/2004WO2004052939A2 Ligands for metals and improved metal-catalyzed processes based thereon
06/24/2004WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004WO2004052846A1 Tetrahydro-naphthalene derivatives
06/24/2004WO2004052845A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/24/2004WO2004052841A1 Carbidopa prodrugs and uses thereof
06/24/2004WO2004052840A1 Compounds which modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions
06/24/2004WO2004052837A2 Amino substituted hydroxyphenyl benzophenone derivatives
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122244 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example
06/24/2004US20040122181 Vulcanization accelerators
06/24/2004US20040122089 Analogs of andandamide and arvanil have been found to act at receptors; are useful in pain management, used as anti-proliferative/anti-tumor agents, vasodilators, and in other applications
06/24/2004US20040122064 Enzyme inhibitors of both wild type and mutant variants of HIV reverse transcriptase, particularly resistant varieties; e.g.,N-{4-[(acetylamino)sulfonyl]-2-methylphenyl}-2-[4-chloro-2-(3-cyano-5-methylbenzoyl)phenoxy]acetamide
06/24/2004US20040122057 Novel mandelic acid derivatives
06/24/2004US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
06/24/2004US20040122023 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/24/2004US20040122021 High optical purity of both levoratatory and dextrorotatory forms; simple, economic synthesis
06/24/2004US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders
06/24/2004US20040122007 1-aryl-2-hydroxyethyl amides as potassium channel openers
06/24/2004US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders
06/24/2004US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors
06/24/2004US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease
06/24/2004DE10258671A1 New bis(trifluoromethyl)amide salts of cationic heterocyles, useful e.g. as ionic liquids and as intermediates for pharmaceuticals and plant-protection agents
06/24/2004CA2506732A1 Compounds which modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
06/23/2004EP1431278A1 Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor
06/23/2004EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
06/23/2004EP1430041A2 Novel sulfonic acid derivatives
06/23/2004EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
06/23/2004EP1429771A2 Bicyclic compounds as inhibitors of chemokine binding to us28
06/23/2004EP1429767A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1246817B1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
06/23/2004EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
06/23/2004CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity
06/23/2004CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation
06/22/2004US6753447 Functionalized monomers for synthesis of rubbery polymers
06/22/2004US6753429 1,4-disubstituted benzenes as insecticides
06/22/2004US6753426 Antiinflammatory agents; autoimmune disease
06/22/2004US6753336 Melanin concentrating hormone receptor ligands
06/22/2004US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries
06/22/2004CA2179418C Pesticides
06/22/2004CA2135309C Process for preparing n-aliphatic substituted p-phenylenediamines
06/17/2004WO2004050648A1 Method for producing salts of tolperisone
06/17/2004WO2004050647A2 Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
06/17/2004WO2004050623A1 Methods for preparing phenylalkyne derivatives
06/17/2004WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same
06/17/2004WO2004050610A2 Modulators of melanocortin receptor
06/17/2004WO2004050022A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/17/2004WO2004037796A3 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
06/17/2004WO2004035534A3 Novel compounds having a dopaminergic and/or serotoninergic activity
06/17/2004WO2004026811A3 Succinic acid semi-amides as anti-corrosives agents
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004US20040116518 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
06/17/2004US20040116456 Remedies for psychoneurosis
06/17/2004US20040116445 Substituted thioacetamides
06/17/2004US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders
06/17/2004US20040116415 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
06/17/2004US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
06/17/2004US20040116404 Sulphones which modulate the action of gamma secretase
06/17/2004US20040116355 Caspase inhibitors and the use thereof
06/17/2004US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
06/17/2004CA2508914A1 Modulators of melanocortin receptor
06/17/2004CA2508487A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/17/2004CA2507875A1 Methods for preparing phenylalkyne derivatives
06/17/2004CA2488114A1 Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
06/16/2004EP1428822A2 1-phenylpiperazine derivative as modulators of dopamine neurotransmission
06/16/2004EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications
06/16/2004EP1428533A2 Use of thiazolidine- or pyrrolidine-derivatives of aminoacids as antihyperglycemic agents
06/16/2004EP1427701A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides
06/16/2004EP1427526A1 Modified alumina catalyst
06/16/2004EP1282597B1 METHOD FOR THE PRODUCTION OF w-AMINOALKYLSULPHONIC ACIDS
06/16/2004EP1244643B1 Tryptase inhibitors
06/16/2004EP0973730B1 Calcilytic compounds
06/16/2004CN1505607A Peptide-deformylase inhibitors
06/16/2004CN1505603A Substituted benzoic ac id derivatives exhibiting nf-ª—b inhibiting activity
06/16/2004CN1153763C Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives
06/16/2004CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds
06/16/2004CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders
06/15/2004US6750355 Derivatives of 2-aminophenol; providing good oxidative coloration of hair and for providing acceptable light fastness, selectivity, fastness to shampooing
06/15/2004US6750339 Primary intermediates for oxidative coloration of hair
06/15/2004US6750337 Couplers for use in oxidative hair dyeing
06/15/2004US6750254 Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
06/15/2004US6750238 Aralkyl ester soft drugs
06/15/2004US6750216 Kappa agonist compounds and pharmaceutical formulations thereof
06/10/2004WO2004048351A2 Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
06/10/2004WO2004048335A2 Mandelic acid derivatives
06/10/2004WO2004048321A1 Phenylsulfoxide and phenylsulfone derivatives
06/10/2004WO2004048319A1 Novel benzamide compounds for use in mch receptor related disorders
06/10/2004WO2004048309A1 Vitamin d receptor modulators
06/10/2004WO2004047743A2 1-aryl-2-hydroxyethyl amides as potassium channel openers
06/10/2004WO2004047738A2 Arylcyclopropylcarboxylic amides as potassium channel openers